These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 32889653)

  • 41. NEUROTOXICITY OF METAL MIXTURES.
    Lopes de Andrade V; Marreilha Dos Santos AP; Aschner M
    Adv Neurotoxicol; 2021; 5():329-364. PubMed ID: 34263093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploring the Role of CLU in the Pathogenesis of Alzheimer's Disease.
    Uddin MS; Kabir MT; Begum MM; Islam MS; Behl T; Ashraf GM
    Neurotox Res; 2021 Dec; 39(6):2108-2119. PubMed ID: 32820456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
    Behl T; Kaur I; Fratila O; Brata R; Bungau S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early-life Pb exposure as a potential risk factor for Alzheimer's disease: are there hazards for the Mexican population?
    Chin-Chan M; Cobos-Puc L; Alvarado-Cruz I; Bayar M; Ermolaeva M
    J Biol Inorg Chem; 2019 Dec; 24(8):1285-1303. PubMed ID: 31773268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease.
    Mroczko B; Groblewska M; Litman-Zawadzka A; Kornhuber J; Lewczuk P
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.
    Pereira C; Agostinho P; Moreira PI; Cardoso SM; Oliveira CR
    Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):383-403. PubMed ID: 16101556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of metal ions on Alzheimer's disease.
    Liu F; Zhang Z; Zhang L; Meng RN; Gao J; Jin M; Li M; Wang XP
    Brain Behav; 2022 Mar; 12(3):e2527. PubMed ID: 35212185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Environmental toxins and Alzheimer's disease progression.
    Vasefi M; Ghaboolian-Zare E; Abedelwahab H; Osu A
    Neurochem Int; 2020 Dec; 141():104852. PubMed ID: 33010393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cu(II) interaction with amyloid-beta peptide: a review of neuroactive mechanisms in AD brains.
    Lin CJ; Huang HC; Jiang ZF
    Brain Res Bull; 2010 Jul; 82(5-6):235-42. PubMed ID: 20598459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology.
    Hossain MF; Uddin MS; Uddin GMS; Sumsuzzman DM; Islam MS; Barreto GE; Mathew B; Ashraf GM
    Mol Neurobiol; 2019 Dec; 56(12):8255-8276. PubMed ID: 31209782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Hardy J; Selkoe DJ
    Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metal homeostasis in Alzheimer's disease.
    White AR; Barnham KJ; Bush AI
    Expert Rev Neurother; 2006 May; 6(5):711-22. PubMed ID: 16734519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oxidative stress in Alzheimer's disease.
    Smith MA; Rottkamp CA; Nunomura A; Raina AK; Perry G
    Biochim Biophys Acta; 2000 Jul; 1502(1):139-44. PubMed ID: 10899439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of oxidative stress and other pathologies in Alzheimer's disease.
    Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
    Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alzheimer's disease: as it was in the beginning.
    Kozlov S; Afonin A; Evsyukov I; Bondarenko A
    Rev Neurosci; 2017 Nov; 28(8):825-843. PubMed ID: 28704198
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.
    Liu Z; Li T; Li P; Wei N; Zhao Z; Liang H; Ji X; Chen W; Xue M; Wei J
    Oxid Med Cell Longev; 2015; 2015():352723. PubMed ID: 26171115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
    Bloom GS
    JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of metals in the etiology of Alzheimer's disease.
    Shcherbatykh I; Carpenter DO
    J Alzheimers Dis; 2007 May; 11(2):191-205. PubMed ID: 17522444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation.
    Ashrafian H; Zadeh EH; Khan RH
    Int J Biol Macromol; 2021 Jan; 167():382-394. PubMed ID: 33278431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.